Variant surface antigens in cerebral malaria: distinct from others and similar to each other? by Aubouy, Agnès et al.
ORAL PRESENTATION Open Access
Variant surface antigens in cerebral malaria:
distinct from others and similar to each other?
Agnès Aubouy
1*, Nabila Kheliouen
1,2, Nicaise Tuikue-Ndam
1,2, Firmine Viwami
1, Francis Lalya
3,
Else C Eboumbou Moukoko
4,5, Christophe Rogier
4, Philippe Deloron
1,2
From Parasite to Prevention: Advances in the understanding of malaria
Edinburgh, UK. 20-22 October 2010
Immunological protection against Plasmodium falci-
parum blood stages is mainly antibody mediated [1,2].
Variant surface antigens (VSA) expressed on the surface
of P. falciparum-infected red blood cells constitute a
key for parasite sequestration and immune evasion [3].
In distinct malaria clinical presentations, as placental
malaria, specific antibody response against VSA provides
protection [4].
In the current study, we investigated in distinct clinical
groups of malaria patients, the antibody response specifi-
cally directed against VSA expressed by parasites isolated
from a given clinical presentation, and particularly
isolates obtained from cerebral malaria (CM) patients.
Plasma and isolates were obtained from four groups of
Beninese subjects: healthy adults (HA, n = 34), patients
presenting uncomplicated malaria (UM, n = 62), cerebral
malaria (CM, n = 41), or pregnancy-associated malaria
(PAM, n = 24). Isolates were tested for their clonality by
msp1 and msp2 genotyping. The reactivity of plasma
samples from each clinical group was measured by flow
cytometry against parasites isolated from individuals
from each clinical group.
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Figure 1 Relative levels of VSA specific IgG to heterologous P.falciparum isolates according to the clinical origin of the P. falciparum isolates, and
to the plasma group. PG: primigravidae, MG: multigravidae. Errors bars indicate standard errors. Groups were compared all together by ANCOVA
(*** P <.0005, * P <.05, ns. non significant), and two factor ANOVA (
§§§ P < .0005,
§§ P < .005,
§ P < .05).
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any medium, provided the original work is properly cited.The levels of clonality were similar in isolates from all
clinical origins. In healthy adults and children presenting
UM, VSAUM antibody levels were higher than VSACM
antibody levels (Figure 1). In both PAM plasma groups
(primigravidae and multigravidae), antibody levels
against the three types of isolates were similar. One
month after infection the level of anti-VSA antibodies
able to recognize heterologous VSACM variants was
increased in CM patients. In UM patients, antibody
levels directed against heterologous VSAUM were similar
during the infection and one month later (Figure 2).
The existence of shared VSACM epitopes was shown
but does not necessarily involve prevalent epitopes.
Prevalence is more probably due to a fine balance
between transmission intensity, antibody repertoire and
environmental factors.
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Figure 2 Acquisition of VSA-specific IgG during the month following P. falciparum infection in plasmas samples from UM (n = 121) and CM (n =
56) patients. UM (A, B) or CM (C, D) plasma samples were tested against P. falciparum isolates from UM patients (A, D) or from CM patients (B, C).
Centerlines indicate medians, boxes indicate the 25th and 75th percentiles of data points, bars indicate the 10th and 90th percentiles and circles
are outliers. Differences are derived from the Wilcoxon rank test for paired comparisons, ns: non significant.
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